ARCTURUS THERAPEUTICS HOLDINGS INC. Shareholders' Equity
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) had Shareholders' Equity of $171.81 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $171.81M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $191.36M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $213.99M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $224.56M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $171.81M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $191.36M 10-Q · filed 2026-08-06 |
| 2025-12-31 | $213.99M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $224.56M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $231.05M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $233.76M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $240.98M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $261.87M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $258.58M 10-Q · filed 2025-11-12 |
| 2024-03-31 | $263.97M 10-Q · filed 2025-11-12 |
| 2023-12-31 | $278.51M 10-K · filed 2026-03-03 |
| 2023-09-30 | $280.06M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $285.18M 10-Q · filed 2024-11-07 |
| 2023-03-31 | $329.25M 10-Q · filed 2024-11-07 |
| 2022-12-31 | $270.31M 10-K · filed 2026-03-03 |
| 2022-09-30 | $145.67M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $170.72M 10-Q · filed 2023-11-14 |
| 2022-03-31 | $184.75M 10-Q · filed 2023-11-14 |
| 2021-12-31 | $228.21M 10-K · filed 2025-03-06 |
| 2021-09-30 | $259.13M 10-Q · filed 2022-11-09 |
| 2021-06-30 | $305.65M 10-Q · filed 2022-11-09 |
| 2021-03-31 | $352.61M 10-Q · filed 2022-11-09 |
| 2020-12-31 | $396.55M 10-K · filed 2024-03-14 |
| 2020-09-30 | $261.63M 10-Q · filed 2021-11-09 |
| 2020-06-30 | $93.42M 10-Q · filed 2021-11-09 |
| 2020-03-31 | $16.98M 10-Q · filed 2021-08-10 |
| 2019-12-31 | $25.79M 10-K · filed 2022-03-01 |
| 2019-09-30 | $35.90M 10-Q · filed 2020-11-09 |
| 2019-06-30 | $21.62M 10-Q · filed 2020-11-09 |
| 2019-03-31 | $6.35M 10-Q · filed 2020-08-10 |
| 2018-12-31 | $13.64M 10-K · filed 2022-03-01 |
| 2018-09-30 | $14.15M 10-Q · filed 2019-11-08 |
| 2018-06-30 | $17.80M 10-Q · filed 2019-11-08 |
| 2018-03-31 | $27.55M 10-Q · filed 2019-08-14 |
| 2017-12-31 | $33.79M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |